MM_Hub: CONGRESS|#EHA2021|Maria Mateos, University of Salamanca, immune based approaches can improve disease control over time. moAB targeting CD-38 e.g. Dara & Dara-Rd has improved the outcomes. CAR-T cell incorporation in 1st line of therapy was also discussed #mmsm #myeloma

by | Jun 14, 2021 | Twitter | 0 comments

CONGRESS|#EHA2021|Maria Mateos, University of Salamanca, immune based approaches can improve disease control over time. moAB targeting CD-38 e.g. Dara & Dara-Rd has improved the outcomes. CAR-T cell incorporation in 1st line of therapy was also discussed #mmsm #myeloma pic.twitter.com/vj9Hfijk9z

— Multiple Myeloma Hub (@MM_Hub) June 14, 2021

Submit a Comment